A species of gram-negative enterobacteria found in WATER; SEWAGE; SOIL; and FOOD. It can be present in any clinical specimen as an opportunistic pathogen.
A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.
Infections with bacteria of the family ENTEROBACTERIACEAE.
Abscess of the PSOAS MUSCLES resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.
A species of gram-negative bacteria in the genus CITROBACTER, family ENTEROBACTERIACEAE. As an important pathogen of laboratory mice, it serves as a model for investigating epithelial hyperproliferation and tumor promotion. It was previously considered a strain of CITROBACTER FREUNDII.

Myocarditis in sibling boxer puppies associated with Citrobacter koseri infection. (1/23)

Two sibling Boxer puppies presented with severe suppurative myocarditis in the absence of additional disseminated suppurative foci. The identification of gram-negative bacteria within areas of myocarditis in both puppies and the pure growth of large numbers of Citrobacter koseri from the myocardial lesions in one of the dogs were consistent with a bacterial etiology. The fact that C. koseri is an opportunist pathogen suggested intercurrent immunosuppression. The finding of a concomitant bacterial myocarditis in two canine siblings is novel. The case is also unusual in that syncope could be related to the myocardial injury.  (+info)

Citrobacter koseri brain abscess in the neonatal rat: survival and replication within human and rat macrophages. (2/23)

A unique feature of Citrobacter koseri is the extremely high propensity to initiate brain abscesses during neonatal meningitis. Previous clinical reports and studies on infant rats have documented many Citrobacter-filled macrophages within the ventricles and brain abscesses. It has been hypothesized that intracellular survival and replication within macrophages may be a mechanism by which C. koseri subverts the host response and elicits chronic infection, resulting in brain abscess formation. In this study, we showed that C. koseri causes meningitis and brain abscesses in the neonatal rat model, and we utilized histology and magnetic resonance imaging technology to visualize brain abscess formation. Histology and electron microscopy (EM) revealed that macrophages (and not fibroblasts, astrocytes, oligodendrocytes, or neurons) were the primary target for long-term C. koseri infection. To better understand C. koseri pathogenesis, we have characterized the interactions of C. koseri with human macrophages. We found that C. koseri survives and replicates within macrophages in vitro and that uptake of C. koseri increases in the presence of human pooled serum in a dose-dependent manner. EM studies lend support to the hypothesis that C. koseri uses morphologically different methods of uptake to enter macrophages. FcgammaRI blocking experiments show that this receptor primarily facilitates the entry of opsonized C. koseri into macrophages. Further, confocal fluorescence microscopy demonstrates that C. koseri survives phagolysosomal fusion and that more than 90% of intracellular C. koseri organisms are colocalized within phagolysosomes. The ability of C. koseri to survive phagolysosome fusion and replicate within macrophages may contribute to the establishment of chronic central nervous system infection including brain abscesses.  (+info)

SHV-34: an extended-spectrum beta-lactamase encoded by an epidemic plasmid. (3/23)

OBJECTIVES: To elucidate the causes for treatment failure in children given extended-spectrum cephalosporins. METHODS: During April 1998-March 2000, 18 isolates of members of the family Enterobacteriaceae, fulfilling microbiological criteria for carriage of extended-spectrum beta-lactamases (ESBLs) and carrying blaSHV, were isolated from paediatric inpatients. The collection was subjected to a retrospective molecular analysis. RESULTS: Three species were represented in the collection: Citrobacter koseri (one isolate), Escherichia coli (one isolate) and Klebsiella pneumoniae (16 isolates). A common plasmid was found in these bacteria, as judged by restriction endonuclease digestion. This was able to transfer an ESBL phenotype from donors to a laboratory strain of E. coli. Nucleotide sequence analysis revealed that this phenotype was associated with a new variant in blaSHV encoding SHV-34. CONCLUSIONS: Analysis reveals the presence of an epidemic plasmid in this collection of bacteria. This carries a gene encoding the SHV-34 ESBL, described for the first time in this report. Nucleotide sequence analysis shows that there is a mutation from A-->G affecting the codon at amino acid position 64 (GAA-->GGA), changing the glutamic acid typically seen in this position to glycine.  (+info)

Citrobacter koseri and Citrobacter amalonaticus isolates carry highly divergent beta-lactamase genes despite having high levels of biochemical similarity and 16S rRNA sequence homology. (4/23)

OBJECTIVES: Isolates previously identified as Citrobacter diversus are now known as Citrobacter koseri. We measured sequence variation at the beta-lactamase structural gene among a group of clinical isolates originally identified as C. diversus by API 20E profiling. METHODS: beta-Lactamase and 16S rRNA genes were amplified by PCR and sequenced by standard methods. beta-Lactamase induction was attempted in liquid-grown cultures using cefoxitin. Nitrocefin hydrolysis assays were performed using a spectrophotometer. RESULTS: Analysis of 16S rRNA gene sequences showed that Citrobacter spp. isolates with an inducible beta-lactamase gene, cdiA, closely related to 'C. koseri ' NF85 and ULA27 are actually Citrobacter amalonaticus. C. koseri isolates, whose identities were confirmed by 16S rRNA sequencing, produce a class A beta-lactamase, Cko, constitutively at low levels. The cko and cdiA beta-lactamase genes share <45% identity. CONCLUSIONS: We have confirmed that cko is a beta-lactamase gene carried by C. koseri, and that isolates previously identified as 'C. koseri ', but carrying the cdiA beta-lactamase gene are C. amalonaticus. Thus, beta-lactamase-gene-specific PCR may provide a valuable tool to differentiate these biochemically homogeneous Citrobacter species.  (+info)

Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate. (5/23)

A new natural TEM derivative with extended-spectrum beta-lactamase activity, TEM-134, was identified in a ceftazidime-resistant clinical isolate of Citrobacter koseri. Compared to TEM-1, TEM-134 contains the following mutations: Q39K, E104K, R164H, and G238S. The bla(TEM-134) gene was not transferable by conjugation and, apparently, was chromosomally encoded. Expression studies with Escherichia coli revealed efficient cefotaximase and ceftazidimase activity for TEM-134.  (+info)

Diffuse pneumocephalus in neonatal Citrobacter meningitis. (6/23)

Pneumocephalus, intracranial air or gas collection, associated with neonatal meningitis is extremely rare. We report the first case in the United States and the second case in the world of intracranial gas accumulation in a neonate with Citrobacter koseri meningitis. The clinical presentation was acute with pneumocephalus demonstrated by cranial sonography and computed tomography. The clinical course was fatal despite the prompt administration of antibiotics.  (+info)

fliP influences Citrobacter koseri macrophage uptake, cytokine expression and brain abscess formation in the neonatal rat. (7/23)

Citrobacter koseri causes neonatal meningitis frequently complicated with multiple brain abscesses. During C. koseri central nervous system infection in the neonatal rat model, previous studies have documented many bacteria-filled macrophages within the neonatal rat brain and abscesses. Previous studies have also shown that C. koseri is taken up by, survives phagolysosomal fusion and replicates in macrophages in vitro and in vivo. In this study, in order to elucidate genetic and cellular factors contributing to C. koseri persistence, a combinatory technique of differential fluorescence induction and transposon mutagenesis was employed to isolate C. koseri genes induced while inside macrophages. Several banks of mutants were subjected to a series of enrichments to select for gfp : : transposon fusion into genes that are turned off in vitro but expressed when intracellular within macrophages. Further screening identified several mutants attenuated in their recovery from macrophages compared with the wild-type. A mutation within an Escherichia coli fliP homologue caused significant attenuation in uptake and hypervirulence in vivo, resulting in death within 24 h. Furthermore, analysis of the immunoregulatory interleukin (IL)-10/IL-12 cytokine response during infection suggested that C. koseri fliP expression may alter this response. A better understanding of the bacteria-macrophage interaction at the molecular level and its contribution to brain abscess formation will assist in developing preventative and therapeutic strategies.  (+info)

Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital. (8/23)

OBJECTIVES: Kinetic characterization of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant isolated from Citrobacter koseri during an Italian nationwide survey. TEM-134 is a natural derivative of TEM-2 with the following substitutions: E104K, R164H and G238S. METHODS: Recombinant TEM-134 was purified from Escherichia coli HB101 (pMGP-134) by three chromatographic steps (cation-exchange chromatography, gel permeation and fast chromatofocusing). Steady-state kinetic parameters (K(m) and k(cat)) were determined by measuring substrate hydrolysis under initial rate conditions using the Hanes linearization of the Michaelis-Menten equation. Modelling was carried out using the software Modeller (version 9.1). RESULTS: TEM-134 hydrolysed with variable efficiency (k(cat)/K(m) ranging from 5 x 10(3) to 8.0 x 10(5) M(-1) . s(-1)) penicillins, narrow-spectrum cephalosporins, cefepime, cefotaxime, ceftazidime and aztreonam, which appeared to be the best substrate. Molecular modelling of the enzyme indicated that the R164H substitution may result in a compromised omega loop in TEM-134 and this may be responsible for its narrower spectrum of activity. CONCLUSIONS: Kinetic data and molecular modelling suggested that R164H has a mild detrimental effect on the global activity of the enzyme.  (+info)

Citrobacter koseri (formerly known as Citrobacter diversus) is a gram-negative, facultatively anaerobic, motile, and encapsulated bacterium that belongs to the family Enterobacteriaceae. It is commonly found in soil, water, and the gastrointestinal tracts of humans and animals.

Citrobacter koseri can cause a range of infections in humans, including urinary tract infections, pneumonia, sepsis, and meningitis, particularly in immunocompromised individuals or neonates. It is also known to cause nosocomial infections, which are acquired in healthcare settings.

Citrobacter koseri is resistant to many antibiotics, including ampicillin and cephalosporins, making it difficult to treat infections caused by this bacterium. Therefore, accurate identification and appropriate antimicrobial therapy are essential for the successful management of Citrobacter koseri infections.

Citrobacter is a genus of facultatively anaerobic, gram-negative, rod-shaped bacteria that are commonly found in the environment, including water, soil, and the gastrointestinal tracts of animals and humans. Members of this genus are capable of fermenting various sugars and producing acid and gas as end products. Some species of Citrobacter have been associated with human diseases, particularly in individuals with weakened immune systems or underlying medical conditions. Infections caused by Citrobacter can include urinary tract infections, pneumonia, bloodstream infections, and meningitis.

"Escherichia" is a genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the intestines of warm-blooded organisms. The most well-known species in this genus is "Escherichia coli," or "E. coli," which is a normal inhabitant of the human gut and is often used as an indicator of fecal contamination in water and food. Some strains of E. coli can cause illness, however, including diarrhea, urinary tract infections, and meningitis. Other species in the genus "Escherichia" are less well-known and are not typically associated with disease.

Enterobacteriaceae are a large family of gram-negative bacteria that are commonly found in the human gut and surrounding environment. Infections caused by Enterobacteriaceae can occur when these bacteria enter parts of the body where they are not normally present, such as the bloodstream, urinary tract, or abdominal cavity.

Enterobacteriaceae infections can cause a range of symptoms depending on the site of infection. For example:

* Urinary tract infections (UTIs) caused by Enterobacteriaceae may cause symptoms such as frequent urination, pain or burning during urination, and lower abdominal pain.
* Bloodstream infections (bacteremia) caused by Enterobacteriaceae can cause fever, chills, and sepsis, a potentially life-threatening condition characterized by a whole-body inflammatory response to infection.
* Pneumonia caused by Enterobacteriaceae may cause cough, chest pain, and difficulty breathing.
* Intra-abdominal infections (such as appendicitis or diverticulitis) caused by Enterobacteriaceae can cause abdominal pain, fever, and changes in bowel habits.

Enterobacteriaceae infections are typically treated with antibiotics, but the increasing prevalence of antibiotic-resistant strains of these bacteria has made treatment more challenging in recent years. Preventing the spread of Enterobacteriaceae in healthcare settings and promoting good hygiene practices can help reduce the risk of infection.

A psoas abscess is a localized collection of pus (infectious material) in the iliopsoas muscle compartment, which consists of the psoas major and iliacus muscles. These muscles are located in the lower back and pelvis, responsible for flexing the hip joint.

Psoas abscesses can be classified as primary or secondary:

1. Primary psoas abscess: This type is caused by hematogenous spread (dissemination through the blood) of a bacterial infection from a distant site, often involving the gastrointestinal tract, genitourinary system, or skin. It is less common and typically seen in individuals with compromised immune systems.
2. Secondary psoas abscess: This type is caused by direct extension of an infection from a nearby anatomical structure, such as the spine, vertebral column, or retroperitoneal space (the area behind the peritoneum, the lining of the abdominal cavity). Common causes include spinal osteomyelitis (spinal bone infection), discitis (infection of the intervertebral disc), or a perforated viscus (a hole in an organ like the bowel).

Symptoms of a psoas abscess may include lower back pain, hip pain, fever, chills, and difficulty walking. Diagnosis typically involves imaging studies such as CT scans or MRIs, which can confirm the presence and extent of the abscess. Treatment usually consists of antibiotic therapy and drainage of the abscess, often through a percutaneous (through the skin) approach guided by imaging. In some cases, surgical intervention may be necessary for adequate drainage and management.

'Citrobacter freundii' is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that is commonly found in the environment, including water, soil, and plants. It is also part of the normal gut flora in humans and animals. The bacterium can cause various types of infections in people with weakened immune systems, such as newborns, the elderly, and those with chronic diseases. Infections caused by 'Citrobacter freundii' may include urinary tract infections, pneumonia, bloodstream infections, and wound infections. Proper identification and antibiotic susceptibility testing are crucial for effective treatment of these infections.

Citrobacter rodentium is a gram-negative, facultative anaerobic, rod-shaped bacterium that belongs to the family Enterobacteriaceae. It is a natural pathogen in mice and has been used as a model organism to study enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) infections in humans, due to its similar virulence mechanisms. C. rodentium primarily colonizes the large intestine, causing inflammation, diarrhea, and weight loss in mice. It is not considered a significant human pathogen, but there have been rare reports of Citrobacter species causing opportunistic infections in immunocompromised individuals.

"Citrobacter koseri". NCBI Taxonomy Browser. 545. Type strain of Citrobacter koseri at BacDive - the Bacterial Diversity ... Citrobacter koseri, formerly known as Citrobacter diversus, is a Gram-negative non-spore forming, rod-shaped bacterium. It is a ... Citrobacter koseri may be identified in the walls of congested vessels, presence of the cavities resulting from the infection ... "Species Citrobacter koseri". LPSN. Retrieved 21 April 2023. Ong CL, Beatson SA, Totsika M, Forestier C, McEwan AG, Schembri MA ...
Deveci A, Coban AY (September 2014). "Optimum management of Citrobacter koseri infection". Expert Review of Anti-Infective ...
Citrobacter koseri was found in an immunocompetent adult. Neisseria bacilliformis was found in a person with a bicuspid aortic ... "Infective endocarditis due to Citrobacter koseri in an immunocompetent adult". Journal of Clinical Microbiology. 47 (12): 4185- ...
Furthermore, Aeromonas hydrophila, Citrobacter koseri (Citrobacter diversus), Pantoea agglomerans (Enterobacter agglomerans), ... It is known to be effective against a wide range of bacteria including Citrobacter, Enterobacter, E. coli, Haemophilus, ...
... species are differentiated by their ability to convert tryptophan to indole (C. koseri is the only citrobacter to ... V. Drelichman; J. D. Band (1985). "Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, ... Citrobacter is a genus of Gram-negative coliform bacteria in the family Enterobacteriaceae. The species C. amalonaticus, C. ... Citrobacter shows the ability to accumulate uranium by building phosphate complexes. These bacteria can be found almost ...
Streptococcus pyogenes Aerobic Gram-negative microorganisms Citrobacter koseri (Citrobacter diversus) Enterobacter aerogenes ...
... such as Citrobacter koseri and Cronobacter sakazakii for example. Ultrasounds are useful for early imaging to determine ...
Citrobacter MeSH B03.440.450.425.200.275 - Citrobacter freundii MeSH B03.440.450.425.200.475 - Citrobacter koseri MeSH B03.440. ... Citrobacter MeSH B03.660.250.150.100.210 - Citrobacter freundii MeSH B03.660.250.150.100.475 - Citrobacter koseri MeSH B03.660. ... 450.425.200.737 - Citrobacter rodentium MeSH B03.440.450.425.260 - Edwardsiella MeSH B03.440.450.425.260.340 - Edwardsiella ... 250.150.100.737 - Citrobacter rodentium MeSH B03.660.250.150.160 - Edwardsiella MeSH B03.660.250.150.160.340 - Edwardsiella ...
"Citrobacter koseri". NCBI Taxonomy Browser. 545. Type strain of Citrobacter koseri at BacDive - the Bacterial Diversity ... Citrobacter koseri, formerly known as Citrobacter diversus, is a Gram-negative non-spore forming, rod-shaped bacterium. It is a ... Citrobacter koseri may be identified in the walls of congested vessels, presence of the cavities resulting from the infection ... "Species Citrobacter koseri". LPSN. Retrieved 21 April 2023. Ong CL, Beatson SA, Totsika M, Forestier C, McEwan AG, Schembri MA ...
name=ExuR regulon. species= Citrobacter koseri ATCC BAA-895. (optional)size=8. ...
... the Texas Department of State Health Services received notification of Enterobacter cloacae and Citrobacter freundii ... the Texas Department of State Health Services received notification of Enterobacter cloacae and Citrobacter freundii ... Citrobacter koseri. Bloodstream. 6. 8. Intra-articular injection, lumbar spine. Aug 29, 2018. Pain clinic. Pain. Sep 4, 2018. ... Enterobacter cloacae, Citrobacter freundii. Bloodstream, cellulitis at injection site§ 9. 11. Intra-articular injection, ...
Citrobacter braakii Citrobacter koseri Mycoplasma hominis Proteus mirabilis human RPP30 DNA Product Insert ... Citrobacter koseri, Mycoplasma hominis, Proteus mirabilis). This kit detects: Citrobacter braakii. Citrobacter koseri. ... Home / DNA / Bacterial-UTI3 multiplexed qPCR Kit = Wound3 (Citrobacter braakii, Citrobacter koseri, Mycoplasma hominis, Proteus ... Cy5 (Proteus mirabilis), Cy5.5 (Mycoplasma hominis), FAM (Citrobacter braakii), HEX (RPP30), TexasRED615 (Citrobacter koseri) ...
Citrobacter koseri protein. Multicopper oxidase CueO. A0A066Q875_ECOLX (A0A066Q875). Escherichia coli protein. Blue copper ...
Citrobacter koseri Citrobacter freundii Edwardsiella tarda Enterobacter aerogenes Enterobacter cloacae Klebsiella oxytoca ...
Citrobacter koseri * Enterobacter asburiae Anaerobic Bacteria. Gram-positive Bacteria * Eggerthella lenta * Parvimonas micra ... Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Fusobacterium nucleatum, Klebsiella aerogenes, Klebsiella oxytoca ...
Citrobacter koseri (diversus) meningitis in an otherwise healthy adolescent. Prais D, Nussinovitch M, Harel L, Amir J. Prais D ...
Citrobacter freundii complex. Citrobacter koseri. Klebsiella aerogenes. Klebsiella oxytoca. Morganella morganii. Proteus ...
A case of Citrobacter koseri renal abscess and review of the literature. SAGE Open Med Case Rep. 2022. 10:2050313X221135347. [ ... Although C koseri has been isolated with increased frequency from the urine of hospitalized patients, fewer than 6 reported ...
Citrobacter koseri. Human urine. PHL, Göteborg, Sweden. 1968-08-29. 178 A. Comamonas testosteroni. Secretion. Gen.Diagn.Dept., ... Citrobacter freundii. Human. Gen.Diagn.Dept., PHL, Göteborg, Sweden. 1968-04-01. ...
... and Citrobacter koseri. If these organisms produce an AmpC β-lactamase, the below approaches for AmpC-producing isolates can be ... Detection of an AmpC β-lactamase in Klebsiella spp., Salmonella spp., C. koseri, or P. mirabilis is confirmatory for plasmid- ... First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. ... koseri, P. mirabilis, and E. coli in areas where the ACC-1 and ACC-4 enzymes are not encountered (so far not detected in the ...
Nosocomial Citrobacter koseri urosepsis in an 87-year-old woman: a case-report. Infectious Diseases & Tropical Medicine 2018; 4 ...
Citrobacter koseri Active Synonym false false 2618883011 Citrobacter diversus Active Synonym false false ...
Citrobacter koseri. Clostridium novyi/Clostridium septicum. Clostridium perfringens. Enterobacter spp.. Enterobacter cloacae ...
Citrobacter koseri 1. Staphylococcus epidermidis 1. Total. 88. Abbreviations: GBS, Group B-Streptococcus; MRSA, methicillin- ...
Citrobacter koseri 1 1.4 Citrobacter spp. 1 1.4 Morganella morgani 1 1.4 ... a Citrobacter spp. resistant to cephalothin, and cefoxitin; Enterobacter resistant to amoxicillin-clavulanate, and cefuroxime; ...
Citrobacter koseri. Enterobacter aerogenes. Haemophilus influenzae (ampicillin-resistant). Haemophilus parainfluenzae. ... Citrobacter freundii. Enterobacter cloacae. Escherichia coli. Haemophilus influenzae. Klebsiella oxytoca. Klebsiella pneumoniae ... of age and older for the treatment of complicated intra-abdominal infections caused by susceptible isolates of Citrobacter ...
Citrobacter koseri. 0%. 0%. 0%. 0%. Citrobacter koseri. 100%. 0%. 49.55%. 0%. Escherichia albertii. 0%. 0%. 0%. 0%. Escherichia ... Citrobacter koserig+wgs, Escherichia albertiig+wgs, Escherichia colig+p+wgs, Escherichia fergusoniig+p+wgs, Escherichia ...
Citrobacter freundii. Citrobacter koseri. Enterobacter aerogenes. Enterobacter cloacae. Haemophilus influenzae. Haemophilus ... Enterococcus faecalis, Staphylococcus aureus (penicillinase-producing strains)*, Staphylococcus epidermidis, Citrobacter ... Citrobacter species, Enterobacter species, Escherichia coli, Klebsiella species, Morganella morganii, Proteus vulgaris, ...
Citrobacter koseri. Clostridium novyi/Clostridium septicum. Clostridium perfringens. Enterobacter spp.. Enterobacter cloacae ...
Citrobacter koseri. *Citrobacter freundii. *Klebsiella oxytoca. *Nitrofurantoin is not active against most strains of Proteus ...
Citrobacter koseri. Moraxella catarrhalis. Morganella morganii. Neisseria gonorrhoeae. Proteus mirabilis. Proteus vulgaris. ...
My dog passed away 1 week ago from Citrobacter Freundii. She was extremely sick with ... . Please help Im scared out of my ... Citrobacter (6) * Citrobacter freundii (4) * Citrobacter koseri (2) * Citrobacter rodentium (0) * Edwardsiella (0) ... in Citrobacter freundii by Helene i live in Canada. My dog passed away 1 week ago from Citrobacter Freundii. She was extremely ...
Citrobacter koseri ATCC BAA-895 Position: -311. Score: 5.93565. Sequence: TTGTAATTTTATTACAA Locus tag: CKO_01111. Name: hexR. ...
Citrobacter koseri ATCC BAA-895. Nickel (Ni). hypothetical protein CKO_04926 nikA. 376377261. EHS90032.1. FASTA. Klebsiella ... Citrobacter rodentium ICC168. Nickel (Ni). nikA gene product nikA. 376397791. EHT10421.1. FASTA. Klebsiella oxytoca 10-5250. ...
Citrobacter koseri, Enterococcus saccharolyticus, Streptococcus gallolyticus). Our study provides guidance to veterinarians for ...
x[which((x$genus == Citrobacter & x$species == koseri). , (x$genus == Citrobacter & x$species == freundii). ... x[which((x$genus == Citrobacter & x$species == freundii). , (x$genus == Citrobacter & x$species == koseri). ...
  • On September 17, 2018, the Texas Department of State Health Services received notification of Enterobacter cloacae and Citrobacter freundii bloodstream infections in three patients who had received injections or infusions of non-FDA-approved umbilical cord blood-derived stem cell products processed by Genetech, Inc., and distributed by Liveyon, LLC, for other than hematopoietic or immunologic reconstitution at an outpatient clinic on September 12. (cdc.gov)
  • Citrobacter freundii complex sp. (embl-heidelberg.de)
  • Has my dog infected it's citrobacter Freundii bacteria to my family? (lookformedical.com)
  • My dog passed away 1 week ago from Citrobacter Freundii. (lookformedical.com)
  • The species C. amalonaticus, C. koseri, and C. freundii can use citrate as a sole carbon source. (labtestsguide.com)
  • In this study, we characterised the genes encoding type 3 fimbriae from CAUTI strains of Escherichia coli , Klebsiella pneumoniae , Klebsiella oxytoca , Citrobacter koseri and Citrobacter freundii . (biomedcentral.com)
  • Citrobacter koseri, formerly known as Citrobacter diversus, is a Gram-negative non-spore forming, rod-shaped bacterium. (wikipedia.org)
  • Citrobacter species are differentiated by their ability to convert tryptophan to indole, ferment lactose, and use malonate. (labtestsguide.com)
  • If incubated for 24 hours in other media such as indole, citrate, and adonitol, C. koseri will be positive, hydrogen sulfide negative in Kligers' iron agar, negative results in lactose, salicin, and sucrose broth as well. (wikipedia.org)
  • Early and massive tissue necrosis is a specific feature of C. koseri brain infection. (wikipedia.org)
  • Citrobacter koseri may be identified in the walls of congested vessels, presence of the cavities resulting from the infection do not develop well-formed fibrotic wall. (wikipedia.org)
  • The prognosis of the C. koseri infection is 20 to 30% of neonates die, and 75% of survivors have significant neurologic damage such as complex hydrocephalus, neurologic deficits, mental delay, and epilepsy. (wikipedia.org)
  • In addition to medical treatment and prompt surgical debridement, we used dialkyl carbamoyl chloride-coated dressing and povidone-iodine sugar ointment for antiseptic dressings and successfully treated neonatal necrotizing fasciitis with gas gangrene caused by peripherally inserted central catheter infection with Citrobacter koseri . (springeropen.com)
  • Infections caused by C. koseri can lead to a range of symptoms, including fever, chills, diarrhea, and abdominal pain. (wikipedia.org)
  • C. koseri may have a unique ability to penetrate, survive, and replicate into vascular endothelial cells and macrophages. (wikipedia.org)
  • Enterobacter sakazakii ), Citrobacter koseri and Arcobacter spp. (foodmicrobe.com)
  • 1] C. koseri may act as an opportunistic pathogen in individuals who are immunocompromised. (wikipedia.org)
  • If incubated for 24 hours in other media such as indole, citrate, and adonitol, C. koseri will be positive, hydrogen sulfide negative in Kligers' iron agar, negative results in lactose, salicin, and sucrose broth as well. (wikipedia.org)
  • The differential diagnosis of C. koseri brain abscesses can be confused with other related diseases, so diagnostic imaging is important to confirm this bacterium. (wikipedia.org)